Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People?s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for the treatment of chronic hepatitis B. Its current product line also includes 5 other OTC products, 10 prescription-based pharmaceuticals, 6 nutriceuticals or health products, and 1 medical device. The company?s OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products include Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchia
|Shares Outstanding||EPS||-2.88||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-64.01%||Sales Growth - Q/Q||-51.97%||P/E||-0.45|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||5.42%||ROE||6.04%||ROI|
|Current Ratio||5.02||Quick Ratio||4.97||Long Term Debt/Equity||Debt Ratio||0.11|
|Gross Margin||48.25%||Operating Margin||-2.61%||Net Profit Margin||7.94%||Dividend Payout Ratio|
|Cash From Financing Activities||-160 K||Cash From Investing Activities||-1.66 M||Cash From Operating Activities||2.84 M||Gross Profit||3.58 M|
|Net Profit||-160 K||Operating Profit||-890 K||Total Assets||80.79 M||Total Current Assets||41.31 M|
|Total Current Liabilities||8.23 M||Total Debt||2.95 M||Total Liabilities||8.23 M||Total Revenue||6.91 M|
|High 52 week||1.68||Low 52 week||0.14||Last close||0.15||Last change||7.14%|
|RSI||16.67||Average true range||0.01||Beta||0.45||Volume||20.42 K|
|Simple moving average 20 days||-6.54%||Simple moving average 50 days||-27.47%||Simple moving average 200 days||-34.03%|
|Performance Week||-6.25%||Performance Month||-6.25%||Performance Quart||-11.76%||Performance Half||3.45%|
|Performance Year||-88.46%||Performance Year-to-date||-52.38%||Volatility daily||6.23%||Volatility weekly||13.93%|
|Volatility monthly||28.54%||Volatility yearly||98.87%||Relative Volume||54.9%||Average Volume||5.23 K|
|New High||New Low|
2018-07-27 08:10:00 | Today's Research Reports on Stocks to Watch: Biostar Pharmaceuticals and ABIOMED
2018-07-25 15:00:00 | Biostar Pharmaceuticals Received Nasdaq Delisting Notification
2018-06-04 14:18:20 | How Does Biostar Pharmaceuticals Inc NASDAQ:BSPM Affect Your Portfolio Returns?
2018-05-30 15:00:00 | Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
2018-05-08 10:02:15 | Cheap Stocks To Invest In
2018-04-23 16:00:00 | Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
2018-04-10 10:23:17 | Who Are The Major Shareholders Of Biostar Pharmaceuticals Inc NASDAQ:BSPM?
2018-03-20 10:02:16 | Best Cheap Stocks To Buy
2018-03-08 15:55:31 | Is Biostar Pharmaceuticals Inc NASDAQ:BSPM A Financially Sound Company?
2018-02-21 09:00:00 | Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform
2018-02-11 09:02:15 | Best Undervalued Stock in February
2018-02-07 09:00:00 | Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
2018-02-01 08:05:00 | Biostar Pharma Post Huge Gains, Pipeline Review, and a New Product
2018-01-28 19:46:45 | Why Biostar Pharmaceuticals Inc NASDAQ:BSPM May Not Be As Efficient As Its Industry
2017-12-29 08:02:41 | December Undervalued Opportunities – Biostar Pharmaceuticals And More
2017-12-04 16:30:00 | Biostar Regains Compliance with NASDAQ Continued Listing Requirement
2017-11-24 08:02:23 | Network-1 Technologies And Other Top Undervalued Stocks
2017-11-03 18:49:27 | Is Biostar Pharmaceuticals Inc’s BSPM Balance Sheet Strong Enough To Weather A Storm?
2017-10-09 11:26:00 | 3 Trending Biotech Stocks To Watch On Monday
2017-08-28 16:00:00 | Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
2016-11-21 16:05:51 | BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
2016-11-14 01:17:12 | Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing
2016-10-18 16:30:00 | Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing
2016-10-11 15:30:36 | Biostar Pharma Skyrockets on New Chinese Product Launch
2016-10-11 08:00:00 | Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis
2016-09-22 16:32:26 | BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
2016-08-27 13:04:27 | BIOSTAR PHARMACEUTICALS, INC. Financials
2016-08-22 16:04:40 | BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
2016-06-24 13:30:52 | Why Are These Five Stocks Trending Today?
2016-06-15 16:26:08 | BioStar Pharmaceuticals, Inc.: Gathering momentum, can it sustain its performance?